Announcement on Progress in Repurchasing Shares
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
Shanghai Yizhong Pharmaceutical Co. Ltd. has announced progress on its share repurchase plan. The company has repurchased a total of shares, representing a small percentage of its total share capital. The repurchase aims to maintain the company's value and protect shareholder interests. The announcement includes details on the repurchase price range and total amount spent so far.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/shanghai-yizhong-pharmaceutical-co-ltdannouncement-on-progress-in-repurchasing-shares
Shanghai Yizhong Pharmaceutical Co. Ltd. on 6ix
Earlier from Shanghai Yizhong Pharmaceutical
- Announcement on Shareholding Increase by the Actual Controller
- Announcement on Cumulative Repurchase of 1% Shares through Call Auction and Progress of Share Repurchase
- Announcement on Initial Repurchase of Shares through Call Auction
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
Later from Shanghai Yizhong Pharmaceutical
- Announcement on the Company and Its Wholly-owned Subsidiaries Using Certain Idle Raised Funds for Cash Management
- Voluntary Disclosure Announcement on Receipt of a Notice of Approval for Drug Clinical Trial for the Investigational Innovative Drug YXC-001
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial for the Investigational Innovative Drug YXC-002
- Announcement on the Grant of Reserved Restricted Shares to Participants under the 2026 Restricted Share Incentive Plan
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
Follow Shanghai Yizhong Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Yizhong Pharmaceutical